Bristol-Myers Squibb Cash Flow Statement
View: Annual | Quarterly
| Quarter Ending Sep 09 |
Quarter Ending Jun 09 |
Quarter Ending Jun 09 |
Quarter Ending Mar 09 |
Quarter Ending Mar 09 |
|
|---|---|---|---|---|---|
| Net Operating Cash Flow | -- | -- | 1,248.0 | -- | -- |
| Net Investing Cash Flow | -- | -- | (1,364.0) | -- | -- |
| Net Financing Cash Flow | -- | -- | (355.0) | -- | -- |
| Net Change in Cash | -- | -- | (469.0) | -- | -- |
| Depreciation & Amortization | -- | -- | 332.0 | -- | -- |
| Capital Expenditures | -- | -- | (365.0) | -- | -- |
| Cash Dividends Paid | -- | -- | (1,231.0) | -- | -- |
© 2009 Morningstar, Inc. Financial Data provided by
